Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
failed trials
Biotech
For Sage drug, Huntington's fail completes clean sweep of flops
The hat trick of failures drove Sage to drop plans for further development of the NMDA receptor positive allosteric modulator.
Nick Paul Taylor
Nov 20, 2024 8:35am
Kronos shelves sole clinical drug over neurological side effects
Nov 14, 2024 5:14am
Syros flunks phase 3 blood cancer trial, triggering loan default
Nov 13, 2024 10:00am
AbbVie's $9B schizophrenia prospect flunks phase 2 trials
Nov 11, 2024 10:06am
Rapt's share price sinks after shelving AD drug under FDA hold
Nov 11, 2024 9:44am
Novo Nordisk discards $1.3B kidney drug in wake of phase 3 fail
Nov 6, 2024 4:54am
